When should palliative care be offered to cancer patients?
The value of innovation in oncology – new recommendations from the European Cancer Patient Coalition
Screening for lung cancer in the UK: progress and considerations
The use of molecular imaging to determine which patient should receive which targeted therapy
Issues with pharmaceutical research funding
Wim van Harten